Additional studies in progress suggest that ARV-825 may also be effective in maximizing the response to estrogen deprivation (aromatase inhibition), another component of ordinary of care in ER+ breast cancer. For all stream cytometry experiments, 10,000 cells for each replicate had been analyzed,